Sign in
4

Changes in Ownership

UroGen Pharma Ltd. Filed Acc 0001209191-20-005200

Chief Medical Officer sold 322 shares at $29.15 ($9,386)

  • Chief Medical Officer acquired 833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schoenberg Mark · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-01-26 Exercise or conversion : show line 1 in the form +833 9,499 D
2020-01-27 Sale : show line 2 in the form −322 $29.15 $9,386 9,177 D
Open-market sales · 322 sh · avg $29.15 · $9,386

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2020-01-26 Exercise or conversion : show line 3 in the form Restricted Stock Units (RSUs) −833 833 1,667 D
Loading xslF345X03/doc4.xml…